about
The crystal structure of myelin oligodendrocyte glycoprotein, a key autoantigen in multiple sclerosisThe directed differentiation of human iPS cells into kidney podocytesIn vivo multi-modal imaging of experimental autoimmune uveoretinitis in transgenic reporter mice reveals the dynamic nature of inflammatory changes during disease progression.A novel unbiased proteomic approach to detect the reactivity of cerebrospinal fluid in neurological diseasesGeneration of induced pluripotent stem cells from human kidney mesangial cellsComparative study on the therapeutic potential of neurally differentiated stem cells in a mouse model of multiple sclerosis.MOG transmembrane and cytoplasmic domains contain highly stimulatory T-cell epitopes in MS.Nogo-receptor 1 deficiency has no influence on immune cell repertoire or function during experimental autoimmune encephalomyelitis.B-cell very late antigen-4 deficiency reduces leukocyte recruitment and susceptibility to central nervous system autoimmunity.Amnion cell-mediated immune modulation following bleomycin challenge: controlling the regulatory T cell responseImmunosuppressive potential of human amnion epithelial cells in the treatment of experimental autoimmune encephalomyelitisGraphene Functionalized Scaffolds Reduce the Inflammatory Response and Supports Endogenous Neuroblast Migration when Implanted in the Adult BrainB-cell activation influences T-cell polarization and outcome of anti-CD20 B-cell depletion in central nervous system autoimmunityAPP intracellular domain acts as a transcriptional regulator of miR-663 suppressing neuronal differentiation.CNS accumulation of regulatory B cells is VLA-4-dependent.Myelin-reactive antibodies initiate T cell-mediated CNS autoimmune disease by opsonization of endogenous antigen.B cell-derived transforming growth factor-β1 expression limits the induction phase of autoimmune neuroinflammation.Molecular grafting onto a stable framework yields novel cyclic peptides for the treatment of multiple sclerosis.Transplantation of umbilical cord and bone marrow-derived mesenchymal stem cells in a patient with relapsing-remitting multiple sclerosis.Stem cell and gene therapeutic strategies for the treatment of multiple sclerosis.Novel therapeutic targets for axonal degeneration in multiple sclerosis.Application of human induced pluripotent stem cells for modeling and treating neurodegenerative diseases.Quantitative and phenotypic analysis of bone marrow-derived cells in the intact and inflamed central nervous system.Neural differentiation of patient specific iPS cells as a novel approach to study the pathophysiology of multiple sclerosis.Granulocyte macrophage colony-stimulating factor: a new putative therapeutic target in multiple sclerosis.Quantitative proteome profiling of CNS-infiltrating autoreactive CD4+ cells reveals selective changes during experimental autoimmune encephalomyelitis.Gene therapy delivery of myelin oligodendrocyte glycoprotein (MOG) via hematopoietic stem cell transfer induces MOG-specific B cell deletion.3D presentation of a neurotrophic factor for the regulation of neural progenitor cells.Distinct immunomodulatory and migratory mechanisms underpin the therapeutic potential of human mesenchymal stem cells in autoimmune demyelination.Human adipose-derived mesenchymal stem cells engineered to secrete IL-10 inhibit APC function and limit CNS autoimmunity.Optimizing interfacial features to regulate neural progenitor cells using polyelectrolyte multilayers and brain derived neurotrophic factor.Early detection of the chemical changes occurring during the induction and prevention of autoimmune-mediated demyelination detected by FT-IR imaging.Incomplete Freund's adjuvant enhances locomotor performance following spinal cord injury.Mesenchymal stem cells and conditioned medium avert enteric neuropathy and colon dysfunction in guinea pig TNBS-induced colitis.Biomaterials for spinal cord regeneration: outgrowth of presumptive neuronal precursors on electrospun poly(epsilon)-caprolactone scaffolds microlayered with alternating polyelectrolytes.Inactive GSK3β is disturbed in the spinal cord during experimental autoimmune encephalomyelitis, but rescued by stem cell therapy.Microglial cystatin F expression is a sensitive indicator for ongoing demyelination with concurrent remyelinationMethod to impart electro- and biofunctionality to neural scaffolds using graphene-polyelectrolyte multilayersFine structure of neurally differentiated iPS cells generated from a multiple sclerosis (MS) patient: a case studyLithium chloride improves the efficiency of induced pluripotent stem cell-derived neurospheres
P50
Q24685683-5BB14077-47D4-4693-BFB8-E11CD5EE3292Q27316230-40D29DA0-23B4-46E8-AEF2-6C6528DFC378Q30620955-445FA379-C8D2-4D9C-86F3-8EDE7DFAD394Q33851008-ED7221BE-87EB-4AB5-B65E-0247681C2486Q34184650-5312CCE2-DD62-42B9-BE8C-660491579B34Q34238869-8EE895DC-6CA5-4616-A27A-04AD0C0BC7DCQ34370104-48017E99-33BC-4984-AC29-A6DFCA8EC291Q35067696-C1C2B327-4361-4BC6-A651-C69C43DCF7E1Q35514450-67EBBB98-9848-4BD9-A8B4-8C6438837E22Q35562446-B0305593-DB1F-4BB1-B283-55AC5FF396E2Q35689857-3F57B939-39C2-4F59-8E02-5072EB907393Q35957660-E8F060A9-E1F3-4D94-B400-3497E3F2B74AQ36034499-1EE93966-6F22-4018-8D50-1779E84EB6BBQ36347215-5A7D9237-680B-450E-AA7E-0D629A132A54Q36694494-EF02C668-E400-40C7-93FB-8422FE070268Q37014400-627C0B6F-678B-4413-80E4-E53636AE3E66Q37314912-3947AD21-2945-4214-8046-E6F3BEE568A4Q37503343-3D5D8E0D-AEA7-43D5-B007-288237CA1849Q37521318-07832DB6-B2A6-48AE-B72A-0AF10CB3C9DCQ37595555-37D99F82-C97C-4845-A4C1-3ACA2E624AE9Q37744464-3B6E293C-AAB4-40F5-8EEC-97DF4AB247B1Q38210765-F44C1F1C-F264-42CE-A8EC-F98379F00818Q39177434-9A8042B6-C29F-414D-B959-21DC1B13C86CQ39408674-0AD31AD1-1D8A-442E-B7EB-0FB99EFE5324Q42944465-8BA58888-7B36-42D1-8753-041A67DAD92BQ45845904-70604967-2ABC-427B-913A-FA79735C6F7AQ45862484-043783ED-C250-4F02-AFBD-F895BAF01309Q46215273-F61E1AB3-7F8C-42D8-B90D-D41601243C87Q46636028-56F4686D-A83D-4A13-AC73-529A1C7E8D9BQ48182778-10261CC8-DFDC-4739-B42E-9E70B5FD7C2FQ48715843-4FF318AE-3DAC-416D-AA2C-A6F4B2067717Q51788147-A076E769-2ACF-46E4-ADE9-B64BDE052680Q51829925-0F952252-D4C3-442F-83B0-A4595374BB35Q53419188-193B9528-F362-4CFF-91BC-27302EA89A1DQ53421365-4A4D0E02-2B1B-4347-B141-7F9DF54DF30EQ53490661-47FC528E-2B08-4254-8BF8-A0F39C55AADBQ83462742-457451D9-7641-496C-9220-BF9521D6C246Q84585210-192F12E9-20AB-496F-987E-B870052D88CFQ85840481-3D378484-F0CA-4520-84A3-7BFA07440F45Q86833867-8756826D-7FE4-4D0C-818E-213B931F32D4
P50
description
researcher
@en
wetenschapper
@nl
name
Claude C A Bernard
@en
Claude C A Bernard
@nl
type
label
Claude C A Bernard
@en
Claude C A Bernard
@nl
prefLabel
Claude C A Bernard
@en
Claude C A Bernard
@nl
P106
P31
P496
0000-0003-2816-5328